The Changing Market for Drugs to Treat Orphan Diseases

Register now

July 18, 2017

Register Save to Calendar




The environment for payer coverage and reimbursement of new treatments for orphan diseases will become increasingly restrictive in the years to come. In case you missed the QuintilesIMS presentation at the 2017 Market Access Conference, this webinar will offer strategies for effective pricing and broad market access in a time of increasing challenges. At QuintilesIMS, we are in the business of bringing innovative therapies to patients faster. We provide actionable recommendations you can operationalize today, grounded by deep functional expertise, an industry-leading data set and decades of experience serving the life sciences industry.


Adam Sohn
Vice President
QuintilesIMS Consulting Services

William McClellan
Center of Excellence Leader, Launch Excellence